Effect of Influenza Immunization on CYP3A4 Activity in Vivo

Journal of Clinical Pharmacology

Volumn 43, Issue 12, 2003, Pages 1377-1381

  Hayney, Mary S ^a   Muller, Daniel ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Drug metabolism; Erythromycin breath test; Immune activation; Immunizations; Influenza vaccine

Indexed keywords

CYTOCHROME P450 3A4; ENFUVIRTIDE; ERYTHROMYCIN; GAMMA INTERFERON; INFLUENZA VACCINE; VIRUS ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IN VIVO STUDY; INFLUENZA; INFLUENZA VACCINATION; LYMPHOCYTE CULTURE; MALE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGING; CYTOCHROME P-450 ENZYME SYSTEM; CYTOKINES; ERYTHROMYCIN; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED;

EID: 0242552648     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270003260330     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2003; 52:1-34.
2. Hayney MS, Hammes RJ, Fine JP, Bianco JA: Effect of influenza immunization on CYP3A4 activity. Vaccine 2002;20:858-861.
3. Hayney MS, Buck JM: Effect of age and degree of immune activation on CYP3A4 activity after influenza immunization. Pharmacotherapy 2002;22:1235-1238.
4. Watkins PB: Noninvasive tests of CYP3A enzymes, Pharmacogenetics 1994;4:171-184.
5. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270:414-423.
6. Kinirons MT, Crome P: Clinical pharmacokinetic considerations in the elderly: an update. Clin Pharmacokin 1997;33:302-312.
7. Romagnani S: Human TH1 and TH2 subsets: doubt no more. Immunol Today 1991;12:256-257.
8. Turgeon DK, Leichtman AB, Lown KS, et al: P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients. Clin Pharmacol Ther 1994;56:253-260.
9. Centers for Disease Control and Prevention: Advanced Laboratory Techniques for Influenza Diagnosis. Atlanta, GA: Public Health Service, 1975.
10. Donato MT, Guillen MI, Jover R, Castell JV, Gomez-Lechon MJ: Nitric oxide-mediated inhibition of cytochrome P450 by interferon-gamma in human hepatocytes. J Pharmacol Exp Ther 1997;281:484-490.
11. Bleau AM, Levitchi MC, Maurice H, du Souich P: Cytochrome P450 inactivation by serum from humans with a viral infection and serum from rabbits with a turpentine-induced inflammation: the role of cytokines. Br J Pharmacol 2000;130:1777-1784.
12. Griffin DE, Ward BJ: Differential CD4 T cell activation in measles. J Infect Dis 1993;168:275-281.
13. Ward BJ, Griffin DE: Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol 1993;67:171-177.
14. Bernstein ED, Gardner EM, Abrutyn E, Gross P, Murasko DM: Cytokine production after influenza vaccination in a healthy elderly population. Vaccine 1998;16:1722-1731.
15. Trollmo C, Carlsten H, Tarkowski A: Intra-articular immunization induces strong systemic immune response in humans. Clin Exp Immunol 1990;82:384-389.
16. McElhaney JE, Meneilly GS, Pinkoski MJ, Lechelt KE, Bleackley RC: Vaccine-related determinants of the interleukin-2 response to influenza vaccination in healthy young and elderly adults. Vaccine 1995;13:6-10.
17. Abdel-Razzak Z, Loyer P, Fautrel A, et al: Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 1993;44:707-715.
18. Muntane-Relat J, Ourlin JC, Domergue J, Maurel P: Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology 1995;22:1143-1153.
19. Gorski JC, Hall SD, Becker P, Affrime MB, Cutler DL, Haehner-Daniels B: In vivo effects of interleukin-10 on human cytochrome P450 activity. Clin Pharmacol Ther 2000;67:32-43.
20. Shedlofsky SI, Israel BC, McClain CJ, Hill DB, Blouin RA: Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. J Clin Invest 1994;94:2209-2214.
21. Cayol M, Tauveron I, Rambourdin F, et al: Whole-body protein turnover and hepatic protein synthesis are increased by vaccination in man. Clin Sci 1995;89:389-396.
22. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2000;49:1-38.
23. Hayney MS, Buck JM, Muller D: Production of interferon γ and interleukin-10 after inactivated hepatitis A immunization. Pharmacotherapy 2003;23:431-435.
24. Gross PA, Russo C, Teplitzky M, Dran S, Cataruozolo P, Munk G: Time to peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol 1996;3:361-362.
25. Kramer P, McClain CJ: Depression of aminopyrine metabolism by influenza vaccination. N Engl J Med 1981;305:1262-1264.
26. Streetman DS, Bertino JS, Nafziger AN: Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes. Pharmacogenetics 2000;10:187-216.
27. McCrea J, Prueksaritanont T, Gertz BJ, et al: Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity. J Clin Pharmacol 1999;39:1212-1220.
28. Kinirons MT, O'Shea D, Kim RB, et al: Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A. Clin Pharmacol Ther 1999;66:224-231.
29. Kenworthy KE, Bloomer JC, Clarke SE, Houston JB: CYP3A4 drug interactions: correlation of 10 in vitro probe substrates. Br J Clin Pharmacol 1999;48:716-727.
30. Chiou WL, Jeong HY, Wu TC, Ma C: Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization. Clin Pharmacol Ther 2001;70:305-310.